Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis
Clinical trial NCT04550130 · UNKNOWN
Trial details
- NCT number
- NCT04550130
- Sponsor
- TLA, Targeted Immunotherapies AB
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.